ODI PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.55 SEK | +1.34% |
|
+4.14% | +51.00% |
| 30/05 | ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
| 02/05 | ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.09Cr | - | - | - | - | - | |
| 77TCr | ||||||
| 35TCr | - | - | - | - | ||
| 33TCr | ||||||
| 30TCr | ||||||
| 25TCr |
- Stock Market
- Equities
- ODI Stock
- Charts ODI Pharma AB
- Sector Chart
